Literature DB >> 10499071

Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects.

M A González-Gay1, C García-Porrúa.   

Abstract

The vasculitides constitute a heterogeneous group of diseases characterized by blood vessel inflammation and necrosis with different but frequently overlapping clinical and pathologic manifestations. The incidence of these conditions is frequently controversial. To further investigate the incidence and clinical manifestations of vasculitides, we reviewed the spectrum of these diseases in an unselected population of adults (age > 20 years) from northwestern Spain during a 10-year period. From January 1988 through December 1997, 267 adults were diagnosed as having vasculitis. The overall average annual incidence rate of vasculitis in the region of Lugo, Spain, between 1988 and 1997 for the population older than 20 years was 141.54/million. Primary vasculitis (115.04/million for the population older than 20 years; 81.3%), especially giant cell arteritis (GCA) was the most common group. Small vessel primary vasculitis (hypersensitivity vasculitis and Henoch-Schönlein purpura) was the second most common group. Both GCA and small vessel primary vasculitis had a good outcome. However, although less common, patients with medium and small vessel primary vasculitis, in particular those with polyarteritis nodosa, had a high mortality related to the systemic manifestations of the disease or to the immunosuppressive therapy. Among the group of adults with secondary vasculitis (26.51/million; 18.7%), rheumatic diseases and specifically those occurring in the context of rheumatoid arthritis were the most common group. Patients with secondary vasculitis had clinical or laboratory data that may suggest the presence of an underlying disease. In summary, systemic vasculitides are somewhat more common than previously considered. As in other western countries, GCA constitutes the most common type of vasculitis in northwestern Spain. Better physician awareness may contribute to the progressive increase in the recognition of these conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499071     DOI: 10.1097/00005792-199909000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  34 in total

Review 1.  Perspective on future therapy of vasculitis.

Authors:  D T Boumpas; H D Kritikos; N G Daskalakis
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

2.  Systemic vasculitis: epidemiology, classification and environmental factors.

Authors:  D G Scott; R A Watts
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

4.  Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients.

Authors:  Sevil Kamali; Murat Inanc; Ahmet Gul; Lale Ocal; Nuray Gurel Polat; Isin Kilicaslan; Orhan Aral; Meral Konice
Journal:  Rheumatol Int       Date:  2004-09-15       Impact factor: 2.631

Review 5.  The lung in systemic vasculitis: radiological patterns and differential diagnosis.

Authors:  Beatrice Feragalli; Cesare Mantini; Marco Sperandeo; Michele Galluzzo; Giovanni Belcaro; Armando Tartaro; Antonio R Cotroneo
Journal:  Br J Radiol       Date:  2016-02-15       Impact factor: 3.039

Review 6.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 7.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

8.  Dermatologic Diagnosis: Leukocytoclastic Vasculitis.

Authors:  Joseph Einhorn; Joel T Levis
Journal:  Perm J       Date:  2015

9.  Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

Authors:  M A González-Gay; C Garcia-Porrua; M J Rivas; P Rodriguez-Ledo; J Llorca
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

10.  Sex disparities in systemic lupus erythematosus in Northwestern Spain are not due to ethnic diversity.

Authors:  Miguel A González-Gay; María D Alonso; Francisco Martínez-Vázquez; Javier Llorca
Journal:  Rheumatol Int       Date:  2014-09-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.